Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets CA125, a surface protein, or antigen, that is released in excess quantities by some ovarian cancers. The medicine, a monoclonal antibody, would stimulate the immune system to attack the protein–killing the tumors.

The Lewin Group. Saving Lives, Saving Money: Dividends for Americans investing in Alzheimer research. Falls Church, VA: The Lewin Group; 2004

Reference

Title
Saving Lives, Saving Money: Dividends for Americans investing in Alzheimer research
Publisher
The Lewin Group
Publication Date
2004
Authors
The Lewin Group

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Breast cancer incidence rates in women decreased 3.5% per year from 2001-2004, the first decrease observed in 20 years.  
  • Survival rates for colon cancer went from 41 percent to 63 percent between 1975 and 1995.  
  • An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay…  
  • The 5-year survival rate for prostate cancer has increased from 67% to nearly 100% over the past 20 years.  
  • The Impact of Personalized Medicine on Cancer Survival in Years